Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

37.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
37.5K
Ligand Binding Sites02:40

Ligand Binding Sites

12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

33.7K
VSEPR Theory for Determination of Electron Pair Geometries
33.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

412
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
412
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concept mask-aware pruning and augmentation for few sample model compression.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Physics-Informed Optimization for the Sub-Feature-Scale Fabrication of Hollow Microneedles via Digital Light Processing.

Micromachines·2026
Same author

Crystal engineering of manganese nitride thin film electrodes for all-nitride asymmetric supercapacitors.

Chemical communications (Cambridge, England)·2026
Same author

An encyclopedic regulatory and functional atlas of RNA interactomes.

Nature methods·2026
Same author

Interaction-aware dexterous robot for minimally invasive transcanal inner ear interventions.

Nature communications·2026
Same author

Covalent Protein-Conjugated Photosensitizer Efficiently Evokes Immunogenic Cell Death for Cancer Vaccine Preparation.

Journal of medicinal chemistry·2026

Related Experiment Video

Updated: May 7, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K

DrugAssist: a large language model for molecule optimization.

Geyan Ye1, Xibao Cai2, Houtim Lai1

  • 1Tencent AI Lab, Tencent, Shenzhen 518057, China.

Briefings in Bioinformatics
|January 3, 2025
PubMed
Summary

Large language models (LLMs) are now used for drug discovery molecule optimization. DrugAssist, an interactive LLM approach, enhances this process through human-machine dialogue, achieving leading results.

Keywords:
drug discoverylarge language modelmolecule optimization

More Related Videos

Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

9.5K
Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

286

Related Experiment Videos

Last Updated: May 7, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

9.5K
Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

286

Area of Science:

  • Artificial Intelligence in Drug Discovery
  • Computational Chemistry
  • Machine Learning for Molecular Optimization

Background:

  • Large language models (LLMs) demonstrate strong performance across various tasks, prompting their application in drug discovery.
  • Molecule optimization, a crucial step in drug development, remains underexplored by current LLM applications.
  • Existing methods often neglect expert feedback and iterative refinement, key components of successful drug discovery.

Purpose of the Study:

  • To introduce DrugAssist, an interactive LLM-based model for molecule optimization.
  • To address the limitations of non-interactive LLM approaches in drug discovery.
  • To leverage LLM interactivity and generalizability for enhanced molecule optimization.

Main Methods:

  • Developed DrugAssist, an interactive molecule optimization model utilizing human-machine dialogue.
  • Employed LLM's interactivity and generalizability for iterative refinement of molecular properties.
  • Leveraged expert feedback within the optimization loop.

Main Results:

  • DrugAssist achieved state-of-the-art results in both single and multiple property optimization.
  • Demonstrated significant potential in transferability and iterative optimization capabilities.
  • Publicly released the 'MolOpt-Instructions' dataset for LLM fine-tuning in molecule optimization.

Conclusions:

  • Interactive LLM approaches like DrugAssist can significantly advance molecule optimization in drug discovery.
  • The integration of expert knowledge with LLMs offers a promising direction for future research.
  • Publicly available code and data will facilitate further advancements in LLM-driven drug discovery.